AN2 Therapeutics (ANTX) Short-term Investments (2021 - 2026)
AN2 Therapeutics' Short-term Investments was $34.07 million in Q2 2026, down 23.8% from $44.7 million a year earlier but up 7.1% from the prior quarter.
Powered by 
Analysis
AN2 Therapeutics (ANTX) Short-term Investments (2021 - 2026) Analysis & Trends
At the end of FY2025, Short-term Investments at AN2 Therapeutics came in at $38.06 million, down 38.9% from FY2024.
- Short-term Investments shows a four-year compound annual growth rate of -4.9% (FY2021 to FY2025).
- In earlier years, Short-term Investments was $62.27 million in FY2024 (-32.1%), $91.65 million in FY2023 (+33.1%), $68.84 million in FY2022 (+48.2%) and $46.46 million in FY2021.
- Quarterly Short-term Investments has moved between $31.8 million (Q1 2026) and $91.65 million (Q4 2023) over five years.
- Compared with a year earlier, Short-term Investments has declined for eight straight quarters, with an average decline of 34.8% over the last eight quarters.
- The best year-over-year quarter for Short-term Investments over five years was Q1 2023 (growth of 72.5%); the worst was Q1 2025 (a decline of 47.4%).
- Per Business Quant data, ANTX's Short-term Investments in the three quarters before Q2 2026 was $31.8 million (Q1 2026), $38.06 million (Q4 2025) and $43.92 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | AN2 Therapeutics | 162.48 Mn | -121.13 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.07 Mn |
| Mar 31, 2026 | 31.80 Mn |
| Dec 31, 2025 | 38.06 Mn |
| Sep 30, 2025 | 43.92 Mn |
| Jun 30, 2025 | 44.70 Mn |
| Mar 31, 2025 | 47.08 Mn |
| Dec 31, 2024 | 62.27 Mn |
| Sep 30, 2024 | 59.92 Mn |
| Jun 30, 2024 | 77.77 Mn |
| Mar 31, 2024 | 89.52 Mn |
| Dec 31, 2023 | 91.65 Mn |
| Sep 30, 2023 | 91.20 Mn |
| Jun 30, 2023 | 54.45 Mn |
| Mar 31, 2023 | 61.81 Mn |
| Dec 31, 2022 | 68.84 Mn |
| Sep 30, 2022 | 75.58 Mn |
| Jun 30, 2022 | 72.77 Mn |
| Mar 31, 2022 | 35.84 Mn |
| Dec 31, 2021 | 46.46 Mn |
API Access
AN2 Therapeutics Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=ANTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "ANTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=ANTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();